Management of Small Cell Lung Cancer
- 1 December 1999
- Vol. 116 (suppl_3) , 525S-530S
- https://doi.org/10.1378/chest.116.suppl_3.525s
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous ChemotherapyJNCI Journal of the National Cancer Institute, 1997
- Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trialThe Lancet, 1996
- Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1995
- Oral Etoposide and CarboplatinAmerican Journal of Clinical Oncology, 1995
- Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?Lung Cancer, 1994
- Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.Journal of Clinical Oncology, 1994
- Decision Analysis of Hematopoietic Growth Factor Use in Patients Receiving Cancer ChemotherapyJNCI Journal of the National Cancer Institute, 1993
- Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.Journal of Clinical Oncology, 1992
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinomaCancer, 1979